< Back to search
Filter
1

Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients

for
Non-Hodgkin Lymphoma, B-cell Non-Hodgkin Lymphoma (B-NHL),
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 16+

Code: NCT05098613

Phase1, Recruiting

Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial

for
Nodular Lymphocyte Predominant B-Cell Lymphoma,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05886036

Phase2, Recruiting

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

for
Large Cell Lymphoma, Diffuse, Relapsed Cancer,
Location: Charlottesville VA, Detroit MI, Indianapolis IN,
Sponsor: Dipenkumar Modi

Sex: All

Age: 18+

Code: NCT05852717

Phase2, Recruiting

Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL

for
Diffuse Large B-Cell Lymphoma
Location: Des Moines IA, Tacoma WA
Sponsor: AstraZeneca

Sex: All

Age: 65 - 70+

Code: NCT05952024

Phase2, Recruiting

Post-Op Pain Control for Prophylactic Intramedullary Nailing.

for
Bone Metastases, Lymphoma, Multiple Myeloma, Opioid Use, Pain
Location: St Louis MO
Sponsor: St. Louis University

Sex: All

Age: 18+

Code: NCT03823534

Phase3, Recruiting

Interested in new lymphoma trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) for the Treatment of Intermediate or High Grade B-Cell Non-Hodgkin Lymphoma

for
High Grade B-Cell Non-Hodgkin's Lymphoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT05801913

Phase1, Recruiting

A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing

for
Diverticulum, Colon, Colorectal Neoplasms, Crohn Disease,
Location: Atlamonte Springs FL, Port Charlotte FL, Springfield MO
Sponsor: novoGI

Sex: All

Age: 18+

Code: NCT01880918

Recruiting

CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma

for
Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma,
Location: Boston MA
Sponsor: Marcela V. Maus, M.D.,Ph.D.

Sex: All

Age: 18+

Code: NCT06026319

Phase1, Recruiting

Long-term Follow-up Study of Patients Receiving CAR-T Cells

for
Chronic Lymphocytic Leukemia, Lymphomas Non-Hodgkin's B-Cell,
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 18 - 70+

Code: NCT03375619

Recruiting

Study of SGR-1505 in Mature B-Cell Neoplasms

for
Mature B-Cell Neoplasm, Non Hodgkin Lymphoma, DLBCL,
Location: Boston MA, Providence RI, The Bronx NY, New York NY,
Sponsor: Schrödinger, Inc.

Sex: All

Age: 18+

Code: NCT05544019

Phase1, Recruiting

CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma

for
B-Cell Non-Hodgkin Lymphoma-Recurrent,
Location: Columbus OH
Sponsor: Nathan Denlinger

Sex: All

Age: 18+

Code: NCT06209619

Phase1, Recruiting

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

for
Colorectal Carcinoma, Endometrial Carcinoma, Melanoma,
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT04851119

Phase1, Phase2, Recruiting

Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas

for
Cutaneous T Cell Lymphoma, Fungoides Mycosis Sezary Syndrome
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 18+

Code: NCT05956041

Phase2, Recruiting

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

for
DLBCL, Diffuse Large B-Cell Lymphoma
Location: Valhalla NY, Horsham PA, Boca Raton FL, Hialeah FL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT05139017

Phase2, Phase3, Recruiting

Study of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLL

for
Relapsed or Refractory CD19+ B-cell Lymphoma,
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT05963217

Phase1, Recruiting

Phase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas

for
Lymphoma, B-Cell
Location: Charlotte NC, Houston TX
Sponsor: Bantam Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06792734

Phase1, Recruiting

PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapy

for
Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04745949

Phase2, Recruiting

A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL

for
Hodgkin Lymphoma, B-Cell Lymphoma, Relapsed B-cell NHL
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05615636

Phase2, Recruiting

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

for
Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma,
Location: Boston MA, Providence RI, New York NY, Hackensack NJ,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06564038

Phase1, Phase2, Recruiting

Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma

for
T-Cell Lymphoma
Location: Boston MA, New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT05313243

Phase2, Recruiting